Rheumatoid Arthritis

Companies Wishing to Enter the Field of Rheumatoid Arthritis Diagnostics should Aim to Develop a Tool with Both Strong (Business Wire via Yahoo! Finance), Can-Fite Submitted Its Protocol for a Phase IIb Clinical Study of CF101 in Rheumatoid Arthritis Patients to the U.S. (RedNova), Teens rally 'round ill boy, Fear Steals the Day from Amgen